EUVIMEDEUVIMED entdecken
Open Access

Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India

Preeta Kaur Chugh, Pooja Gupta, Himika Wasan, C D Tripathi, Sujith J Chandy, Jaya Ranjalkar, Heber Rew Bright, Dinesh Kumar Badyal, Madhulika Peter Samuel, Ratinder Jhaj, Aditya Banerjee, Rupa Joshi und 26 weitere

Indian Journal of Pharmacology · 2024

DOI: 10.4103/ijp.ijp_61_23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Pharmacology, 2024. Verfasst von Preeta Kaur Chugh und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi, India. Hauptthemen laut MEDLINE: Hypoglycemic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: India has taken several initiatives to provide health care to its population while keeping the related expenditure minimum. Since cardiovascular diseases are the most prevalent chronic conditions, in the present study, we aimed to analyze the difference in prices of medicines prescribed for three cardiovascular risk factors, based on (a) listed and not listed in the National List of Essential Medicines (NLEM) and (b) generic and branded drugs. MATERIALS AND METHODS: Outpatient prescriptions for diabetes mellitus, hypertension, and dyslipidemia were retrospectively analyzed from 12 tertiary centers. The prices of medicines prescribed were compared based on presence or absence in NLEM India-2015 and prescribing by generic versus brand name. The price was standardized and presented as average price per medicine per year for a given medicine. The results are presented in Indian rupee (INR) and as median (range). RESULTS: Of the 4,736 prescriptions collected, 843 contained oral antidiabetic, antihypertensive, and/or hypolipidemic medicines. The price per medicine per year for NLEM oral antidiabetics was INR 2849 (2593–3104) and for non-NLEM was INR 5343 (2964–14364). It was INR 806 (243–2132) for generic and INR 3809 (1968–14364) for branded antidiabetics. Antihypertensives and hypolipidemics followed the trend. The price of branded non-NLEM medicines was 5–22 times higher compared to generic NLEM which, for a population of 1.37 billion, would translate to a potential saving of 346.8 billion INR for statins. The variability was significant for sulfonylureas, angiotensin receptor blockers, beta-blockers, diuretics, and statins ( P < 0.0001). CONCLUSION: The study highlights an urgent need for intervention to actualize the maximum benefit of government policies and minimize the out-of-pocket expenditure on medicines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hypoglycemic AgentsIndiaHumansRetrospective StudiesCardiovascular DiseasesDrugs, GenericHypolipidemic AgentsHeart Disease Risk FactorsDrug CostsHypertensionDiabetes MellitusDyslipidemiasAntihypertensive AgentsCosts and Cost Analysis

Substanzen

Hypoglycemic AgentsDrugs, GenericHypolipidemic AgentsAntihypertensive Agents

Autor:innen und Institutionen

  • Department of Pharmacology, VMMC and Safdarjung Hospital, New Delhi, India.
  • Department of Pharmacology, AIIMS, New Delhi, India.
  • Department of Pharmacology, Government Institute of Medical Sciences, Greater Noida, Uttar Pradesh, India.
  • Department of Pharmacology and Clinical Pharmacology, CMC, Vellore, Tamil Nadu, India.
  • Department of Pharmacology, CMC, Ludhiana, Punjab, India.
  • Department of Pharmacology, AIIMS, Bhopal, Madhya Pradesh, India.

Zitieren

APA

Chugh, P. K., Gupta, P., Wasan, H., Tripathi, C. D., Chandy, S. J., Ranjalkar, J., Bright, H. R., Badyal, D. K., Samuel, M. P., Jhaj, R., Banerjee, A., Joshi, R., Medhi, B., Prakash, A., Kamat, S., Tripathi, R., Shetty, Y., Parmar, U., Dikshit, H., …, & Kshirsagar, N. A. (2024). Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India. Indian Journal of Pharmacology. https://doi.org/10.4103/ijp.ijp_61_23

Vancouver

Chugh PK, Gupta P, Wasan H, Tripathi CD, Chandy SJ, Ranjalkar J, et al. Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India. Indian Journal of Pharmacology. 2024. doi:10.4103/ijp.ijp_61_23

BibTeX
@article{Chugh2024,
  author = {Chugh, Preeta Kaur and Gupta, Pooja and Wasan, Himika and Tripathi, C D and Chandy, Sujith J and Ranjalkar, Jaya and Bright, Heber Rew and Badyal, Dinesh Kumar and Samuel, Madhulika Peter and Jhaj, Ratinder and Banerjee, Aditya and Joshi, Rupa and Medhi, Bikash and Prakash, Ajay and Kamat, Sandhya and Tripathi, Raakhi and Shetty, Yashashri and Parmar, Urwashi and Dikshit, Harihar and Mishra, Hitesh and Roy, Sukalyan Saha and Kumar, Rajiv and Chatterjee, Suparna and Bhattacharya, Manjari and Samanta, Kalyan and Trivedi, Niyati and Shah, Prashant and Chauhan, Janki and Ramasamy, Raveendran and Mathaiyan, Jayanthi and Gauthaman, Jeevitha and Kaushal, Sandeep and Jain, Samriti and Arora, Shalini and Gupta, Kanchan and Cherian, Jerin Jose and Chatterjee, Nabendu Sekhar and Kshirsagar, Nilima Arun},
  title = {Prescription-based cost analysis of medicines for cardiovascular risk factors at Indian Council of Medical Research-Rational Use of Medicine Centre Hospitals of India},
  journal = {Indian Journal of Pharmacology},
  year = {2024},
  doi = {10.4103/ijp.ijp_61_23}
}
Kostenlos starten →